Cargando…

Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations

The recently proposed nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease (MAFLD) has resulted in the reappraisal of epidemiological trends and associations with other chronic diseases. In this context, MAFLD appears to be tightly linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627426/ https://www.ncbi.nlm.nih.gov/pubmed/36338895 http://dx.doi.org/10.3748/wjg.v28.i39.5691

Ejemplares similares

Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017–2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic Scores
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Overview of infections as an etiologic factor and complication in patients with vasculitides
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Chronic Pain and Its Association with Depressive Symptoms and Renal Function in Hypertensive Patients
por: Kalaitzidis, Rigas G., et al.
Publicado: (2022)

Hypertension is the crucial link between obstructive sleep apnea and arterial stiffness
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Tadalafil in patients on antihypertensive medications: Does safety remain an issue?
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Pathophysiology of Acute Coronary Syndromes—Diagnostic and Treatment Considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Should we need more sensitive early diagnostic markers in children with congenital solitary functioning kidneys?
por: G Kalaitzidis, Rigas
Publicado: (2020)

Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
por: Lin, Huapeng, et al.
Publicado: (2021)

Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus
por: Grigoriadis, Gregory, et al.
Publicado: (2023)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Defensive coping and health-related quality of life in chronic kidney disease: a cross-sectional study
por: Kaltsouda, Anna, et al.
Publicado: (2011)

Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
por: Odriozola, Aitor, et al.
Publicado: (2023)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

Sexual and gonadal dysfunction in chronic kidney disease: Pathophysiology
por: Rathi, Manish, et al.
Publicado: (2012)

Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
por: Valenti, Luca, et al.
Publicado: (2022)

Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease
por: Rugivarodom, Manus, et al.
Publicado: (2022)

Cardiorenal Syndrome Type 4—Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management
por: Pateinakis, Panagiotis, et al.
Publicado: (2011)

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Copper Deficiency in Liver Diseases: A Case Series and Pathophysiological Considerations
por: Yu, Lei, et al.
Publicado: (2019)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
por: Manka, Paul P., et al.
Publicado: (2021)

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
por: Sun, Dan-Qin, et al.
Publicado: (2023)

The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
por: Wei, Suosu, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Postprandial dysfunction in fatty liver disease
por: Grandt, Josephine, et al.
Publicado: (2023)

Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease
por: Liang, Tian, et al.
Publicado: (2022)

Cardiovascular Pathophysiology, Epidemiology, and Treatment Considerations of Coronavirus Disease 2019 (COVID-19): A Review
por: Levett, Jeremy Y., et al.
Publicado: (2020)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study
por: Hu, Qian, et al.
Publicado: (2022)

Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
por: D’Elia, John A, et al.
Publicado: (2009)

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
por: Marchisello, Simona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ved4a3b0p96uv6vvliukqi1mui